BiotechTube
Home/Patrys/Peter Christie
PC

Peter Christie

Chairman

Patrys

Therapeutic Areas

OncologyImmunologyNeurology

Patrys Pipeline

DrugIndicationPhase
RLS-2202Acute DeliriumPhase 1
PAT-DX1Vasculitis / Inflammatory DiseasePreclinical
PAT-DX3Vasculitis / Inflammatory DiseasePreclinical
Deoxymab Oncology CandidateSolid Tumor CancerPreclinical

Leadership Team at Patrys

BL
Brian Leedman
Non‑Executive Director
View full Patrys profile